• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION DYNAGEN X4 CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION DYNAGEN X4 CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G158
Device Problems High impedance (1291); Pacing Problem (1439); Incorrect, Inadequate or Imprecise Result or Readings (1535); Inappropriate/Inadequate Shock/Stimulation (1574)
Patient Problem Shock from Patient Lead(s) (3162)
Event Date 03/20/2024
Event Type  Injury  
Event Description
It was reported that this patient with a cardiac resynchronization therapy defibrillator (crt-d) presented to the emergency department, following multiple shock deliveries.Upon interrogation, a code 1005, indicative an open circuit condition, was observed.This alert was declared as the shock impedance was greater than 145 ohms.Additionally, it was confirmed that the patient had received a total of eight shocks, resulting in therapy exhaustion.The physician suspected that the arrhythmia was atrial in origin, with subsequent ventricular conduction, and thus the anti-tachycardia pacing (atp) and shocks that were delivered were inappropriate.Boston scientific technical services was contacted and it was discussed that calcification was possibly the cause of the gradually increasing shock impedance measurements.Right ventricular (rv) lead replacement was recommended, as therapy may not be effective with shock impedance greater than 145 ohms.Additionally, as the crt-d device was nearing end-of-life due to normal battery depletion, potential device replacement during the rv lead revision was also mentioned.At this time, the system remains implanted and in-service.The patient is currently hospitalized and intubated.
 
Event Description
It was reported that this patient with a cardiac resynchronization therapy defibrillator (crt-d) presented to the emergency department, following multiple shock deliveries.Upon interrogation, a code 1005, indicative an open circuit condition, was observed.This alert was declared as the shock impedance was greater than 145 ohms.Additionally, it was confirmed that the patient had received a total of eight shocks, resulting in therapy exhaustion.The physician suspected that the arrhythmia was atrial in origin, with subsequent ventricular conduction, and thus the anti-tachycardia pacing (atp) and shocks that were delivered were inappropriate.Boston scientific technical services was contacted and it was discussed that calcification was possibly the cause of the gradually increasing shock impedance measurements.Right ventricular (rv) lead replacement was recommended, as therapy may not be effective with shock impedance greater than 145 ohms.Additionally, as the crt-d device was nearing end-of-life due to normal battery depletion, potential device replacement during the rv lead revision was also mentioned.The patient is currently hospitalized and intubated.However, the sales representative recently confirmed that no surgical intervention has occurred and at this time, the system remains implanted and in-service.No further information was provided regarding the patient status.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DYNAGEN X4 CRT-D
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key19144326
MDR Text Key340607596
Report Number2124215-2024-23928
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526534904
UDI-Public00802526534904
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010012/S341
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/13/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date04/01/2017
Device Model NumberG158
Device Catalogue NumberG158
Device Lot Number132407
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received04/19/2024
Supplement Dates Manufacturer Received04/19/2024
Supplement Dates FDA Received05/13/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/01/2015
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Other;
Patient Age66 YR
Patient SexMale
-
-